ReviewThe Journal of clinical and aesthetic dermatology2023
Molluscum Contagiosum: Epidemiology, Considerations, Treatment Options, and Therapeutic Gaps.
Review in The Journal of clinical and aesthetic dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Molluscum Contagiosum Treatments in Children: A Systematic Review with Network Meta-Analysis.Paediatric drugs · 2026Pooled it
- The Human Vaginal Virome: Composition, Microbiome Interactions, and Implications for Bacterial Vaginosis, HPV Persistence, and Preterm Birth.Microorganisms · 2026Review
- [1/m with clusters of papules on the body : Preparation for the medical specialist examination: part 70].Dermatologie (Heidelberg, Germany) · 2026Article
- Article
- Eczema Molluscatum in a Patient With Atopic Dermatitis on Upadacitinib and Methotrexate.Cureus · 2026Article
- Reverse vaccinology and immunoinformatics identify multi-epitope vaccine candidates against molluscum contagiosum virus.Biology methods & protocols · 2026Article
- Oral Ranitidine as an Immunomodulatory Agent in the Treatment of Molluscum Contagiosum: A Pediatric Case Report.Cureus · 2025Article
- Article
- Article
- Skin microbiota in atopic dermatitis: victim or executioner?Clinical microbiology reviews · 2025Review
- Beginning of the End (BOTE) Sign in the Setting of Recurrent Molluscum Contagiosum in a Child.Cureus · 2025Article
- Population-Level Impact of Human Papillomavirus Vaccination on the Incidence of Genital Warts in Sweden.The Journal of infectious diseases · 2025Article
- Visualization of Molluscum Contagiosum Virus in FFPE Skin Sections Using NanoSuit-CLEM: Ultrastructural Evidence of Viral Spread via Skin Barrier Disruption.Immunity, inflammation and disease · 2025Article
- Aluminum-based salts: an unorthodox but simple way to treat molluscum contagiosum and cutaneous warts.F1000Research · 2025Review
- Article
- Article
- Article
- Article
- Facial vs Non-facial Molluscum Contagiosum Infection in Children: A Cross-sectional Study.Acta dermato-venereologica · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molluscum contagiosum (MC) is a viral infection that affects primarily pediatric patients, sexually active young adults, and immunocompromised people of all ages. MC occurs all over the world, making up about one percent of skin disorders and appears to be increasing in prevalence. This cutaneous infection is often associated with atopic dermatitis and is typically self-limiting, although spontaneous resolution can take months to years. Many treatments exist, but only one-a drug-device product using topical cantharidin- is approved by the United States (US) Food and Drug Administration (FDA) for treatment of MC. For many years, there was a lack of an established or FDA-approved first-line treatment for MC, which might have contributed to the common "benign neglect" attitude of physicians regarding treatment of MC. Unfortunately, this noninterventional approach can increase risk of spreading infection and result in longer duration of infection, physical discomfort, and psychosocial issues due to persistence of the MC lesions. This article reviews available epidemiology data and explores treatment options and therapeutic gaps in MC management.
Identifiers
37636018PMC10453394W4386209612What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.